XERS Q1 2018 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$982M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$263,000-25.7% YoY

Gross Profit

$221,00084.0% margin

Operating Income

-$12M-4460.1% margin

Net Income

-$12M-4527.4% margin

EPS (Diluted)

$-5.49

QoQ Revenue Growth

-43.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$244,000

Balance Sheet

Total Assets

$62M

Total Liabilities

$29M

Stockholders' Equity

$33M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$263,000	$354,000	-25.7%
Gross Profit	$221,000	$354,000	-37.6%
Operating Income	-$12M	-$5M	-152.3%
Net Income	-$12M	-$5M	-156.1%